Temporospatial distribution and transcriptional profile of retinal microglia in the oxygen-induced retinopathy mouse

Myriam Boeck1, Adrian Thien1, Julian Wolf1

  • 1Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Glia
|March 10, 2020
PubMed

Insights

Resident retinal microglia (MG) are the main myeloid cells in retinal neovascularization (RNV), showing significant proliferation. These activated MG cells present a potential therapeutic target for neovascular eye diseases.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Myeloid cells, including retinal microglia (MG) and blood-derived macrophages (Mϕ), accumulate in retinal ischemia and neovascularization (RNV).
  • The precise roles and distribution of these myeloid cells in neovascular eye disease remain unclear.

Purpose of the Study:

  • To investigate the temporospatial distribution and proliferation of retinal microglia (MG) and macrophages (Mϕ) in a mouse model of oxygen-induced retinopathy (OIR).
  • To analyze the transcriptional profile of MG during retinal ischemia and RNV.

Main Methods:

  • Utilized Cx3cr1CreERT2 :Rosa26-tdTomato reporter mice to track myeloid cells.
  • Employed cell-specific sorting of tdTomato-positive MG via flow cytometry for high-throughput RNA sequencing (RNA Seq).
  • Administered 5-ethynyl-2'-deoxyuridine (EdU) to assess cell proliferation in vivo.

Main Results:

  • Retinal microglia (MG) were the predominant myeloid population in areas of RNV, with macrophages (Mϕ) infiltration being rare.
  • Approximately 30% of MG in RNV areas were EdU-positive, indicating significant local MG proliferation.
  • Gene ontology analysis revealed MG transcriptional changes related to cell division, tubulin binding, and signaling pathways.

Conclusions:

  • Activated retinal MG exhibit substantial proliferative capacity and are the primary myeloid cells in ischemic and neovascular retinal areas in the OIR model.
  • These findings highlight retinal MG as a potential therapeutic target for neovascular eye diseases.

Related Concept Videos